Travere Therapeutics, Inc. (TVTX)
↓ Download CSV- Sector Manufacturing
- Incorporated CA
- Fiscal year ends Dec 31
In fiscal 2025, Travere Therapeutics, Inc. reported revenue of $490.73M, up 110.5% from the prior year. The company ran a net loss, with a net margin of -5.2%. It held $605.19M in total assets against $490.36M in total liabilities.
Key ratios (FY2025)
-12.8%
Operating margin
-5.2%
Net margin
-22.2%
Return on equity
+110.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $490.73M | $233.18M | $145.24M | $109.46M | $131.84M | $198.32M | $175.34M | $164.25M | $154.94M | $133.59M |
| Cost of Revenue | $10.34M | $7.74M | $11.45M | $4.42M | $3.82M | $6.13M | $5.23M | $5.53M | $3.60M | $4.55M |
| Operating Income | -$62.82M | -$323.83M | -$388.14M | -$319.81M | -$199.43M | -$176.16M | -$137.36M | -$80.04M | -$53.79M | -$58.21M |
| Net Income | -$25.55M | -$321.55M | -$111.40M | -$278.48M | -$180.09M | -$169.43M | -$146.43M | -$102.68M | -$59.73M | -$47.90M |
| EPS (Diluted) | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 | $-3.56 | $-3.46 | $-2.54 | $-1.54 | $-1.29 |
| Total Assets | $605.19M | $594.12M | $788.91M | $672.59M | $776.63M | $607.44M | $604.80M | $709.16M | $520.35M | $525.28M |
| Total Liabilities | $490.36M | $535.05M | $588.10M | $629.73M | $474.52M | $396.23M | $383.60M | $390.91M | $227.21M | $217.51M |
| Shareholders' Equity | $114.83M | $59.08M | $200.81M | $42.85M | $302.11M | $211.21M | $221.20M | $318.25M | $293.13M | $307.77M |
| Cash & Equivalents | $93.03M | $58.53M | $58.18M | $61.69M | $165.75M | $84.77M | $62.44M | $102.87M | $99.39M | $41.00M |
| Operating Cash Flow | $37.78M | -$237.47M | -$280.02M | -$186.29M | -$14.79M | -$42.74M | -$58.21M | -$24.96M | $7.40M | -$3.44M |
| Capital Expenditures | — | — | $668.0K | $191.0K | $5.10M | $6.77M | $195.0K | $727.0K | $887.0K | $1.43M |
| Shares Outstanding | 90.92M | 87.45M | 75.37M | 64.29M | 62.49M | 52.25M | 43.09M | 41.39M | 39.37M | 37.91M |